Given ACTA’s and CT:IQs complementary clinical trials sector-boosting focus. Given that ACTA is a CT:IQ founding partner. And that CT:IQ held its launch symposium at ACTA’s Trial of the Year awards event, the ACTA Central Team were never going to say “no” to CT:IQ’s newly appointed Program Director, Leanne Weekes, when she asked if she could co-locate at ACTA’s new offices in South Melbourne.
Welcome Leanne, the coffee’s on you!
In case you missed it, here’s a CT:IQ primer: CT:IQ is modelled on the highly successful US FDA-funded Clinical Trials Transformation Initiative (CTTI). It is co-funded by MTPConnect and ACTA is a foundation partner. CT:IQ is working to advance projects spanning the clinical trials sector – commercial and investigator-initiated – that are distinct from ACTA’s work supporting clinical trials networks, coordinating centres, and registries. The George Institute and CTC are also CT:IQ foundation partners.
Stay in touch with CT:IQ by signing-up for its newsletter.